4DMedical Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FDMDF research report →
Companywww.4dmedical.com
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator.
- CEO
- Andreas Fouras
- IPO
- 2021
- Employees
- 145
- HQ
- Carlton, VIC, AU
Price Chart
Valuation
- Market Cap
- $1.48B
- P/E
- -10.51
- P/S
- 463.23
- P/B
- -59.07
- EV/EBITDA
- -55.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -396.61%
- Op Margin
- -1166.28%
- Net Margin
- -3684.62%
- ROE
- -890.76%
- ROIC
- -37.27%
Growth & Income
- Revenue
- $5.85M · 91.94%
- Net Income
- $-30,069,854 · 16.42%
- EPS
- $-0.07 · 35.55%
- Op Income
- $-29,220,394
- FCF YoY
- -10.88%
Performance & Tape
- 52W High
- $5.00
- 52W Low
- $0.16
- 50D MA
- $3.32
- 200D MA
- $2.04
- Beta
- 1.97
- Avg Volume
- 1.46K
Get TickerSpark's AI analysis on FDMDF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FDMDF Coverage
We haven't published any research on FDMDF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FDMDF Report →